# OnCo record psmafore (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/psmafore/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "psmafore", "NCT04689828" ;
  schema:name "PSMAfore"@en ;
  schema:description "PSMAfore moved Pluvicto before chemotherapy in prostate cancer."@en ;
  schema:url <https://onco.cc/trials/psmafore/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04689828>, <https://www.nice.org.uk/guidance/ta930> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2021-06-15" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:drugs <https://onco.cc/drugs/pluvicto/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:terms <https://onco.cc/terms/prostate-crpc-sequencing/> ;
  onco:trials <https://onco.cc/trials/card/>, <https://onco.cc/trials/vision/>, <https://onco.cc/trials/therap/> ;
  onco:people <https://onco.cc/people/oliver-sartor/>, <https://onco.cc/people/michael-morris/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-psmafore-lancet-2024/> .